Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-21 9:55 pm Purchase | 2025-11-20 | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS, L.P. | 15,045,391 30.200% | 1,500,000 (+11.07%) | Filing History |
| 2025-11-14 6:12 pm Unchanged | 2025-11-12 | 13D | Lineage Cell Therapeutics, Inc. LCTX | BROADWOOD PARTNERS, L.P. | 57,848,357 23.100% | 0 (Unchanged) | Filing History |
| 2025-10-24 8:09 pm Unchanged | 2025-10-22 | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS, L.P. | 13,545,391 27.400% | 0 (Unchanged) | Filing History |
| 2025-10-22 06:08 am Unchanged | 2025-10-21 | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS, L.P. | 13,545,391 27.400% | 0 (Unchanged) | Filing History |
| 2025-09-26 6:43 pm Unchanged | 2025-09-24 | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS, L.P. | 13,545,391 27.400% | 0 (Unchanged) | Filing History |
| 2025-09-17 9:46 pm Unchanged | 2025-09-15 | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS, L.P. | 13,545,391 27.400% | 0 (Unchanged) | Filing History |
| 2025-09-02 08:00 am Unchanged | 2025-09-02 | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS, L.P. | 13,545,391 27.300% | 0 (Unchanged) | Filing History |
| 2025-08-08 07:57 am Purchase | 2025-08-07 | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS, L.P. | 13,545,391 27.300% | 187,227 (+1.40%) | Filing History |
| 2025-04-07 8:40 pm Purchase | 2025-04-04 | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS, L.P. | 13,358,164 27.100% | 845,220 (+6.75%) | Filing History |
| 2025-04-02 8:37 pm Purchase | 2025-03-31 | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS, L.P. | 12,512,944 25.400% | 533,846 (+4.46%) | Filing History |
| 2025-03-03 7:07 pm Purchase | 2025-02-27 | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS, L.P. | 11,979,098 24.300% | 1,184,768 (+10.98%) | Filing History |
| 2025-02-10 8:46 pm Purchase | 2025-02-06 | 13D | Insight Molecular Diagnostics Inc. IMDX | BROADWOOD PARTNERS, L.P. | 11,560,350 40.200% | 6,481,034 (+127.60%) | Filing History |
| 2025-01-28 8:07 pm Purchase | 2025-01-27 | 13D | Lineage Cell Therapeutics, Inc. LCTX | BROADWOOD PARTNERS, L.P. | 57,848,357 24.500% | 15,789,474 (+37.54%) | Filing History |
| 2024-11-21 8:05 pm Purchase | 2024-11-19 | 13D | Lineage Cell Therapeutics, Inc. LCTX | BROADWOOD PARTNERS, L.P. | 42,058,883 19.100% | 75,000 (+0.18%) | Filing History |
| 2024-11-14 5:09 pm Purchase | 2024-09-30 | 13G | Serina Therapeutics, Inc. SER | BROADWOOD PARTNERS, L.P. | 187,871 2.100% | 187,871 (New Position) | Filing History |
| 2024-04-15 7:26 pm Purchase | 2024-04-11 | 13D | Insight Molecular Diagnostics Inc. IMDX | BROADWOOD PARTNERS, L.P. | 5,079,316 37.600% | 5,079,316 (New Position) | Filing History |
| 2024-02-08 6:57 pm Purchase | 2024-02-06 | 13D | Lineage Cell Therapeutics, Inc. LCTX | BROADWOOD PARTNERS, L.P. | 41,983,883 22.200% | 6,756,610 (+19.18%) | Filing History |
| 2024-01-10 5:23 pm Purchase | 2024-01-04 | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS, L.P. | 10,794,330 22.100% | 665,586 (+6.57%) | Filing History |
| 2023-11-15 5:27 pm Purchase | 2023-11-09 | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS, L.P. | 10,128,744 20.700% | 633,121 (+6.67%) | Filing History |
| 2023-10-10 08:00 am Purchase | 2023-10-04 | 13D | STAAR Surgical Company STAA | BROADWOOD PARTNERS, L.P. | 9,495,623 19.600% | 877,716 (+10.18%) | Filing History |